SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022855
Filing Date
2020-05-07
Accepted
2020-05-07 16:12:03
Documents
71
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-10q_20200331.htm   iXBRL 10-Q 3048543
2 EX-10.1 fgen-ex101_190.htm EX-10.1 24363
3 EX-31.1 fgen-ex311_6.htm EX-31.1 8335
4 EX-31.2 fgen-ex312_8.htm EX-31.2 8343
5 EX-32.1 fgen-ex321_7.htm EX-32.1 7821
  Complete submission text file 0001564590-20-022855.txt   10342982

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fgen-20200331.xsd EX-101.SCH 58236
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20200331_cal.xml EX-101.CAL 75751
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20200331_def.xml EX-101.DEF 188841
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20200331_lab.xml EX-101.LAB 427702
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20200331_pre.xml EX-101.PRE 361398
36 EXTRACTED XBRL INSTANCE DOCUMENT fgen-10q_20200331_htm.xml XML 2214621
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 20856486
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences